OBJECTIVE: To report a case in which propofol was used successfully in an intubated patient on a prolonged basis and to review the literature that discusses long-term infusions (> 7 days) of propofol. METHODS: Information was retrieved from a MEDLINE search of the English-language literature. Reports of clinical trials and case reports that compared the safety and efficacy of long-term propofol and midazolam were included in this review. Information about the study design and the efficacy and adverse effects of the drugs was collected, and the data were synthesized. RESULTS: Clinical reports indicate that a long-term infusion of propofol is comparable in safety and efficacy to a long-term infusion of midazolam. The distinct adverse-effect profile of long-term use of propofol, including hypertriglyceridemia, was evaluated and reported as significant. CONCLUSION: The limited data available suggest that long-term infusion of propofol is a practical alternative to use of standard agents for sedation of intubated patients. Adverse effects such as cardiovascular depression, respiratory depression, and hypertriglyceridemia may limit the routine use of propofol.
Articles| January 01 1998
Propofol for the long-term sedation of a critically ill patient
Am J Crit Care (1998) 7 (1): 73–76.
- Views Icon Views
- Share Icon Share
- Tools Icon Tools
- Search Site
LJ Miller, R Wiles-Pfeifler; Propofol for the long-term sedation of a critically ill patient. Am J Crit Care 1 January 1998; 7 (1): 73–76. doi: https://doi.org/10.4037/ajcc1922.214.171.124
Download citation file: